PDA

View Full Version : Medical Articles and Abstracts


Pages : [1] 2 3 4 5

  1. New hemostatic sealant for children undergoing adenoidectomy
  2. Intravenous iron and EPO reduces transfusions in patients with hip fracture
  3. Transfusions in the less severely injured: does age of transfused blood affect out...
  4. A very strict guideline reduces the number of erythrocyte transfusions in preterm...
  5. Eculizumab for Autoimmune Hemolytic Anemia
  6. Actual & potential clinical trials for non-transfusion therapies for hemolytic anemia
  7. sickle cell or other hemolytic anemia - consider looking for clinical trials
  8. Clinical strategies in the medical care of Jehovah's Witnesses
  9. Pharmacokinetic differentiation of drug candidates using system analysis and phy...
  10. Management of postpartum hemorrhage by uterine balloon tamponade: prospective eval...
  11. The unresolved safety concerns of bovine thrombin
  12. Proposed mechanisms for transfusion-related acute lung injury (TRALI)
  13. Red blood cell transfusion and increased mortality in pediatric trauma patients
  14. FDA approves new use of drug in patients with hemophilia A
  15. Role of anemia in traumatic brain injury
  16. “Hemostasis in Subjects Undergoing Spine Surgery”
  17. Hospital Pharmacy (August 2008) “Thrombin, topical (recombinant)”
  18. Clinical use of topical thrombin as a surgical hemostat
  19. Blood Transfusions - Safe Medicine?
  20. Yeast Product in Study Increased Volume of Red Blood Cells
  21. Acute lung injury following blood transfusion: Expanding the definition
  22. Dengue Hemorrhagic Fever Transmitted by Blood Transfusion
  23. Case Report: What Was in Those Platelets?
  24. The silent risks of blood transfusion
  25. Stem Cells Might Lead to Red Blood Cell Production
  26. Survival after blood transfusion
  27. Lessons learned from outcome of bloodless emergency laparotomies on JW women
  28. Treatments for increasing platelet production
  29. Improved survival of critically ill trauma patients treated with recombinant human...
  30. Erythropoiesis-stimulating agents in oncology.
  31. The direct effects of stored blood products may worsen prognosis of cancer patients
  32. Damage control hematology: the impact of a trauma exsanguination protocol on survival
  33. Outcome Analysis of Blood Product Transfusion in Trauma Patients: A Prospective, Risk
  34. Intraoperative Allogeneic Red Blood Cell Transfusion in Ampullary Cancer Outcome ...
  35. Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis
  36. Establishing an association between a peri-operative perfusion score system
  37. Anemia, blood loss, and blood transfusions in North American children in the intensiv
  38. Perioperative anaemia management: consensus statement on the role of intravenous iron
  39. Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in
  40. Transfusion of fresh frozen plasma in critically ill surgical patients is associated
  41. Impact of red blood cell transfusion on clinical outcomes in patients with acute ...
  42. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
  43. Aprotinin is not associated with postoperative renal impairment after primary coro...
  44. Complications associated with anemia and blood transfusion in patients with aneury...
  45. Analysis of blood tx predictors in patients undergoing elective oesophagectomy
  46. IV Iron in Oncology
  47. Promising Finding in Acute Respiratory Distress Syndrome
  48. Recent research results on survival after extreme blood loss
  49. The ongoing variability in blood transfusion practices in cardiac surgery.
  50. A simple technique ligating the corresponding inflow and outflow vessels during anato
  51. SCT in Jehovah's Witnesses: the bloodless transplant.
  52. Patch-and-glue sutureless repair for blowout rupture after myocardial infarction: rep
  53. Bloodless cardiac surgery: not just possible, but preferable.
  54. Current role of bloodless liver resection.
  55. On-line autotransfusion waste calculator
  56. Short-term ferrous sulfate supplementation in female blood donors
  57. Efficacy, safety and compliance of intravenous iron sucrose and in anemia/pregnancy
  58. Short-term ferrous sulfate supplementation in female blood donors
  59. Use of Recombinant Factor VIIa in Life-Threatening Obstetric Postpartum Hemorrhage
  60. Adverse outcomes of blood transfusion in children
  61. The role of blood transfusion in the management of upper and lower intestinal tract b
  62. Duration of red-cell storage and complications after cardiac surgery.
  63. Does perioperative use of aprotinin reduce the rejection rate in heart transplant rec
  64. The decrease of preoperative autologous transfusion in France has not been linked to
  65. Changes in transfusion practice for surgery.
  66. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.
  67. Laparoscopic Cortical-Sparing Adrenalectomy for Bilateral Pheochromocytoma.
  68. ENT surgery, blood and Jehovah's Witnesses.
  69. Successful autologous peripheral blood stem cell transplantation in a JW...
  70. Ruptured heterotopic interstitial pregnancy: rare case... in a JW patient
  71. Acute normovolemic hemodilution... in a JW with placenta percreta.
  72. Anemia Drugs for Cancer Patients Increase Death Risk
  73. Blood Management: A Primer for Clinicians
  74. Legal & Ethical Considerations in Transfusion of Infected or Untested Autologous Bloo
  75. Blood conservation strategies to reduce the need for red blood cell transfusion in...
  76. Transfusion-related acute lung injury: a clinical challenge
  77. Cell salvage in obstetrics
  78. Blood conservation strategies to reduce need red blood cell transfusion critical ill
  79. Case report: Transfusion-related acute lung injury (TRALI) A clear and present danger
  80. Blood transfusion associated with increased resource utilisation, cadiac surgery
  81. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
  82. Novel erythropoiesis-stimulating agents: a new era in anemia management.
  83. Increased risk of infection and mortality in women after cardiac surgery related...
  84. The ideal transfusion trigger in critically ill patients
  85. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a bloo
  86. Prevalence of hepatitis C virus infection at start of hemodialysis in Japan.
  87. Transfusion-related acute lung injury (TRALI) A clear and present danger
  88. A Jehovah's Witness child with hemophilia B... undergoing scoliosis surgery
  89. Foreign blood saving measures in orthopedic surgery
  90. Studies Probe Weaknesses in Donated Blood
  91. Voluven Helps Minimize Surgical Blood Loss
  92. Pathophysiology of TRALI: current concepts.
  93. Am J Respir Crit Care Med.
  94. Experience of a network of transfusion coordinators for blood conservation
  95. Increased mortality, postoperative morbidity, and cost after red blood cell ...
  96. Anemia and Transfusions in Patients Undergoing Surgery for Cancer.
  97. Effect of early blood transfusion on gastrointestinal haemorrhage
  98. Adverse effects of transfusion
  99. Effect of blood transfusion on outcome after major burn injury: a multicenter study
  100. A simple technique ligating the corresponding inflow and outflow vessels during an...
  101. Hemorrhage from DIC controlled by Factor VIIa
  102. Transfusion Alert for Patients with Curable Cancer
  103. Association of Red Cell Transfusion with Mortality in Patients with Acute Lung Injury
  104. Estimating the cost of blood: past, present, and future directions.
  105. Blood conservation in the critically ill.
  106. Impact of blood loss on outcome after liver resection.
  107. Bloodless (Liver) Surgery? The Anesthetist's View.
  108. Pediatric cardiac surgery without homologous blood transfusion, using a ...
  109. The pathogenesis of transfusion-related acute lung injury (TRALI).
  110. West Nile virus adheres to human red blood cells in whole blood.
  111. Anemia Management and Blood Conservation in the Hospital Setting
  112. Improved coagulation and blood conservation in the golden hours after cardiopulmonary
  113. Stored Packed Red Blood Cell Transfusion Up-regulates Inflammatory . . .
  114. Results of major hepatectomy without vascular clamping . . .
  115. The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings
  116. Verses, viruses, and the vulnerability of the blood supply in industrialized countrie
  117. BleedingWeb.com's Free Slide Shows
  118. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not
  119. Transfusion-transmitted infection in hemophilia in developing countries.
  120. Products for clotting factor replacement in developing countries.
  121. Efficacy of recombinant factor VIIa administered by continuous infusion to haemophili
  122. NovoSeven: mode of action and use in acquired haemophilia.
  123. Antidotes to haemorrhage: recombinant factor VIIa.
  124. Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa
  125. Cost-effectiveness of cell salvage and alternative methods of minimising perioperativ
  126. Clinical review -Autologous transfusion.
  127. Blood transfusion medicine
  128. Eliminating Blood Transfusions: New Aspects and Perspectives
  129. Risks, benefits, alternatives and indications of allogenic blood transfusions.
  130. Live Donor Liver Transplantation Without Blood Products
  131. Pre-operative high or low red blood cell count linked with poorer outcomes older pats
  132. Treatments for iron-deficiency anaemia in pregnancy.
  133. Milk iron content in breast-feeding mothers after administration of intravenous iron
  134. A dose exploration, phase I/II study of administration of continuous erythropoietin r
  135. Addition of intravenous iron to epoetin beta increases hemoglobin response and decrea
  136. Clinical update: intravenous iron for anaemia.
  137. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a...
  138. Mortality associated with aprotinin during 5 years following coronary artery bypass g
  139. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular fun
  140. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood tra
  141. Perioperative blood transfusion and blood conservation in cardiac surgery: the Soc...
  142. Association of Red Cell Transfusion with Mortality in Patients with Acute Lung Injury
  143. Blood conservation techniques in obstetrics: a UK perspective
  144. Study Questions Risks of Anti-Bleeding Drug during Heart Surgery - Hartford Hospital
  145. Clinical Guidelines for Blood Conservation During Cardiac Procedures Developed
  146. An economic analysis of costs associated with development of a cell salvage program.
  147. Transfusion Strategies for Patients in Pediatric Intensive Care Units
  148. Minimally invasive cardiopulmonary bypass: does it really change the outcome?
  149. An economic analysis of costs associated with development of a cell salvage program
  150. Fresh frozen plasma and platelet transfusions are associated with . . .
  151. s resuscitation from hemorrhagic shock limited by blood oxygen-carrying . . .
  152. Erythropoietin and iron-restricted erythropoiesis.
  153. Paroxysmal Nocturnal Hemoglobinuria
  154. Prevention and Management of Postpartum Hemorrhage
  155. Management of bleeding following major trauma: a European guideline
  156. Mortality associated with aprotinin during 5 years following coronary artery bypass..
  157. Addition of intravenous iron to epoetin beta increases hemoglobin response and dec...
  158. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001...
  159. Effects of a Restrictive Blood Transfusion Policy on Outcomes in Children With Burn I
  160. Effects of a Restrictive Blood Transfusion Policy on Outcomes in Children With Burn
  161. Budget impact analysis of a blood saving program for urgent traumatological surgery
  162. [Haemorrhage and transfusion: the peculiar case of Jehovah's witnesses]
  163. Thrombotic thrombocytopenic purpura induced by trimethoprim-sulfamethoxazole in a Jeh
  164. Speed of haemoglobin response in patients with cancer: a review of the erythropoietic
  165. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
  166. Recombinant activated factor VII as an adjunctive therapy for bleeding control trauma
  167. The effects of normal as compared with low hematocrit values in patients with cardiac
  168. Improved survival with higher hematocrits: where is the evidence?
  169. Early versus late erythropoietin for preventing red blood cell transfusion in preterm
  170. The Premature Infants in Need of Transfusion (PINT) study
  171. Anemia - More Aggressive Identification And Treatment Needed To Improve Outcomes
  172. Aggressive Anemia Treatment Increases Mortality
  173. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
  174. Prevalence of HIV-1 in blood donations following implementation of a structured ...
  175. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of ...
  176. Effect of low central venous pressure and phlebotomy on blood product transfusion . .
  177. Intraoperative Red Blood-Cell Salvage in Revision Hip Surgery
  178. Transfusion Risks and Transfusion-related Pro-inflammatory Responses
  179. Risk and prevention of transfusion-related sepsis
  180. Bacterial contamination of platelet units
  181. Bacterial contamination of blood products.
  182. Bacterial contamination of blood components: risks, strategies, and regulation
  183. Effect of repeated intravenous iron administration in haemodialysis patients
  184. The use of erythropoietin in patients undergoing radical prostatectomy: effects . . .
  185. Clinical approaches involving thrombopoietin to shorten the period of thrombocytop...
  186. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of...
  187. Anemia - Erythropoietin
  188. How we manage requests for recombinant factor VIIa (NovoSeven).
  189. Hemodilutional anemia impairs neurologic outcome after cardiopulmonary bypass in a...
  190. Transfusion-associated microchimerism: a new complication of blood transfusions in...
  191. The use of hemostatic agents and sealants in urology.
  192. Red cell substitutes.
  193. Blood transfusions are associated with increased risk for development of sepsis...
  194. Pilot Study of Low-tech Garment to Prevent Maternal Death from Postpartum Hemorrhage
  195. Transfusion-related acute lung injury and pulmonary edema in critically ill...
  196. Cell Salvage: Ultrafiltration reduces blood transfusions following cardiac surgery...
  197. Determinants of complications with recombinant factor VIIa for refractory blood loss
  198. Anesthesia Techniques: Effect of low central venous pressure and phlebotomy on blood
  199. Transfusion Practice: Allogeneic blood transfusions explain increased mortality in wo
  200. Changing indications for red cell transfusion from 2000 to 2004 in the North of Engla
  201. Intravenous Iron - Determination of VIT 45 (IND#63,243 - American Regent) removal by
  202. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood
  203. Ultrafiltration reduces blood transfusions following cardiac surgery: a meta-analysis
  204. Aprotinin; friend or foe? A review of recent medical literature.
  205. Latest Advances in Surgical Adhesives and Sealants
  206. Genomics and blood substitutes for 21st century Europe ("EuroBloodSubstitutes").
  207. The Efficacy Of Ugu (Telfaira Occidentals) In The Management of Childhood Anemia:
  208. Resuscitation Of A Jehovah's Witness With Multiple Injuries Without Blood:
  209. Advance Directives: Many Critically Ill Patients Lack
  210. Failure to adopt beneficial therapies caused by bias in medical evidence evaluation
  211. Improved preoperative iron status assessment by soluble transferrin receptor in elder
  212. New approaches to the management of anemia of chronic kidney disease: Beyond Epogen a
  213. Safe and successful restriction of transfusion in burn patients.
  214. Egg on their Faces
  215. MIT material stops bleeding in seconds
  216. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the
  217. Perioperative intravenous iron preserves iron stores and may hasten the recovery from
  218. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the
  219. The use of erythropoietin in patients undergoing radical prostatectomy: effects on he
  220. Cost-effectiveness of cell salvage and alternative methods of minimising perioperativ
  221. Should plasma be transfused prophylactically before invasive procedures?
  222. Resistance of viruses to inactivation in blood products
  223. Surgical site infection following bowel surgery: a retrospective analysis of 1446 pat
  224. The effects of leukoreduced blood transfusion on infection risk following injury: a r
  225. Use of the Hemobag for Modified Ultrafiltration in a Jehovah’s Witness Patient Underg
  226. Significant reduction in blood loss in patients undergoing minimal extracorporeal cir
  227. A novel erythropoietic agent
  228. Intraoperative blood salvage with blood irradiation -- from an anaesthesiological poi
  229. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis
  230. Derivation of a risk index for the prediction of massive blood transfusion in liver t
  231. Impact of a transfusion-free program on non-Jehovah's Witness patients undergoing liv
  232. Assessing the total costs of blood delivery to hospital oncology and haematology pati
  233. A prospective, randomized platelet-function study of heparinized oxygenators and card
  234. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled t
  235. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthropl
  236. Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee
  237. Utilization of platelet transfusions in the intensive care unit: indications, transfu
  238. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patient
  239. Double-blind, placebo-controlled study of quality of life, hematologic end points, an
  240. The value of an albumin-based intravascular volume replacement strategy in elderly pa
  241. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-hea
  242. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery
  243. Blood transfusion is associated with infection and increased resource utilization in
  244. Determinants of complications with recombinant factor VIIa for refractory blood loss
  245. Recombinant factor VIIa and the surgical patient
  246. Prediction of massive blood transfusion in cardiac surgery
  247. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a
  248. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive
  249. Red blood cell transfusions and nosocomial infections in critically ill patients
  250. Developing a blood conservation program in cardiac surgery